Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)

JA Radford, AZS Rohatiner, WDJ Ryder, DP Deakin, T Barbui, N Lucie, A Rossi, DJ Dunlop, RD James, RK Gupta, RA Cowan, J Shamash, J Chang, TA Lister

Research output: Contribution to journalArticlepeer-review

Cite this